Treatment(s) already received-Bone marrow transplant Posts on Medivizor
Navigation Menu

Treatment(s) already received-Bone marrow transplant Posts on Medivizor

Is rituximab maintenance effective long-term for follicular lymphoma after an autologous stem cell transplant?

Is rituximab maintenance effective long-term for follicular lymphoma after an autologous stem cell transplant?

Posted by on Feb 14, 2021 in Non-Hodgkin lymphoma | 0 comments

In a nutshell The authors reviewed rituximab (Rituxan) maintenance (RM) therapy in patients with relapsed follicular lymphoma (FL) treated with an autologous stem cell transplant (ASCT). The study found that RM after ASCT delayed FL relapse after a 12-year follow up. Some background Rituximab and chemotherapy have improved the outcomes of...

Read More

Second stem cell transplant using reduced intensity conditioning for leukemia or lymphoma

Second stem cell transplant using reduced intensity conditioning for leukemia or lymphoma

Posted by on Oct 25, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study aimed to investigate the outcomes of a second hematopoietic stem cell transplant (HSCT) after reduced-intensity conditioning (RIC) for patients with leukemia or lymphoma.   This study concluded that this treatment path is feasible and a good treatment alternative for these patients.   Some background Allogenic...

Read More

Second stem cell transplant using reduced intensity conditioning for leukemia or lymphoma

Second stem cell transplant using reduced intensity conditioning for leukemia or lymphoma

Posted by on Oct 25, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the outcomes of a second hematopoietic stem cell transplant (HSCT) after reduced-intensity conditioning (RIC) for patients with leukemia or lymphoma.   This study concluded that this treatment path is feasible and a good treatment alternative for these patients.   Some background...

Read More

Treating acute myeloid leukemia with FLT3-ITD mutation by sorafenib maintenance after HSCT

Treating acute myeloid leukemia with FLT3-ITD mutation by sorafenib maintenance after HSCT

Posted by on Aug 23, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated outcomes of sorafenib (Nexavar) maintenance therapy after allogeneic hematopoietic stem cell transplantation (alloHSCT) in patients with acute myeloid leukemia (AML) carrying FLT3-ITD mutation. The authors found that sorafenib maintenance therapy decreased the risks of relapse and mortality after HSCT in such...

Read More

The effects of a second autologous stem cell transplantation in patients with relapsed/refractory Hodgkin lymphoma after a first transplant

The effects of a second autologous stem cell transplantation in patients with relapsed/refractory Hodgkin lymphoma after a first transplant

Posted by on Aug 9, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell The study evaluated the outcomes of second autologous stem cell transplantation (ASCT2) in patients with relapsed/refractory Hodgkin lymphoma (r/r-HL) after a first transplantation (ASCT1). The main finding was that ASCT2 was safe and relatively effective in such patients. Some background ASCT replaces cancerous bone marrow with healthy...

Read More

Evaluating cyclophosphamide in patients with acute myeloid leukemia receiving donor transplants

Evaluating cyclophosphamide in patients with acute myeloid leukemia receiving donor transplants

Posted by on May 24, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate post-transplant cyclophosphamide treatment in patients with acute myeloid leukemia. This study concluded that this treatment is safe and effective in these patients.   Some background Post-transplant cyclophosphamide (PTCy) is an immune system suppressant. It can be used after...

Read More

Do stem cell transplants improve patients’ long-term survival?

Posted by on Apr 25, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the long-term survival of patients who received stem cell transplants (SCT) and compared them to the general population. The authors found that patients who received SCTs had almost the same chance of survival as the general population and identified factors that alter this chance. Some background Treatments such as...

Read More

Do stem cell transplants improve patients’ long-term survival?

Posted by on Apr 25, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the long-term survival of patients who received stem cell transplants (SCT) and compared them to the general population. The authors found that patients who received SCTs had almost the same chance of survival as the general population and identified factors that alter this chance. Some background Treatments such as...

Read More

Does stem cell transplantation affect the quality of life of older patients with NHL?

Posted by on Oct 10, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the quality of life reported by elderly patients with non-Hodgkin's lymphoma (NHL) after a stem cell transplant (SCT). The authors concluded that quality of life for these patients was very good following SCT. Some background Autologous SCT is the standard of care in first-line treatment for...

Read More